Helius Medical Technologies Stock Analysis

HSDT Stock  USD 0.55  0  0.55%   
Helius Medical Technologies is undervalued with Real Value of 1.42 and Target Price of 4.0. The main objective of Helius Medical stock analysis is to determine its intrinsic value, which is an estimate of what Helius Medical Technologies is worth, separate from its market price. There are two main types of Helius Medical's stock analysis: fundamental analysis and technical analysis.
The Helius Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Helius Medical is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Helius Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Helius Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Helius Medical Techn recorded a loss per share of 4.27. The entity last dividend was issued on the 4th of January 2021. The firm had 1:50 split on the 17th of August 2023. Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator , is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 19 people. To learn more about Helius Medical Technologies call Dane Andreeff at 215 944 6100 or check out https://heliusmedical.com.

Helius Medical Techn Investment Alerts

Helius Medical Techn is way too risky over 90 days horizon
Helius Medical Techn has some characteristics of a very speculative penny stock
Helius Medical Techn appears to be risky and price may revert if volatility continues
Helius Medical Techn has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 644 K. Net Loss for the year was (8.85 M) with loss before overhead, payroll, taxes, and interest of (16 K).
Helius Medical Technologies currently holds about 3.27 M in cash with (10.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Helius Medical Techn has a frail financial position based on the latest SEC disclosures
Latest headline from globenewswire.com: Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for 3.7 Million Gross Proceeds Priced At-the-Market

Helius Medical Techn Upcoming and Recent Events

14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Helius Largest EPS Surprises

Earnings surprises can significantly impact Helius Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-11
2023-03-31-0.11-0.090.0218 
2018-03-12
2017-12-31-0.15-0.1848-0.034823 
2023-03-09
2022-12-31-0.13-0.17-0.0430 
View All Earnings Estimates

Helius Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Federation Des Caisses Desjardins Du Quebec2024-09-30
32.0
Bank Of America Corp2024-09-30
29.0
Morgan Stanley - Brokerage Accounts2024-09-30
4.0
St Germain D J Co Inc2024-12-31
2.0
The Toronto-dominion Bank2024-09-30
0.0
Armistice Capital, Llc2024-09-30
0.0
Virtu Financial Llc2024-12-31
46.5 K
Susquehanna International Group, Llp2024-09-30
18.2 K
Geode Capital Management, Llc2024-09-30
17.8 K
Two Sigma Securities, Llc2024-09-30
14.2 K
Ubs Group Ag2024-09-30
12.8 K
Note, although Helius Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Helius Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.1 M.

Helius Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.04)(1.09)
Return On Capital Employed(1.92)(2.02)
Return On Assets(1.04)(1.09)
Return On Equity(3.39)(3.56)

Management Efficiency

Helius Medical Techn has return on total asset (ROA) of (1.1256) % which means that it has lost $1.1256 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.598) %, meaning that it created substantial loss on money invested by shareholders. Helius Medical's management efficiency ratios could be used to measure how well Helius Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.09 in 2025. Return On Capital Employed is likely to drop to -2.02 in 2025. At this time, Helius Medical's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 384.8 K in 2025, whereas Total Current Liabilities is likely to drop slightly above 1.6 M in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 3.48  3.31 
Tangible Book Value Per Share 3.44  3.27 
Enterprise Value Over EBITDA 0.02  0.02 
Price Book Value Ratio 1.87  1.97 
Enterprise Value Multiple 0.02  0.02 
Price Fair Value 1.87  1.97 
Enterprise Value-273.2 K-259.5 K
Management at Helius Medical Techn focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Operating Margin
(79.80)
Beta
1.505
Return On Assets
(1.13)
Return On Equity
(2.60)

Technical Drivers

As of the 17th of February 2025, Helius Medical retains the Downside Deviation of 7.56, risk adjusted performance of 0.046, and Market Risk Adjusted Performance of 0.2449. Helius Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Helius Medical Techn Price Movement Analysis

Execute Study
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Helius Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Helius Medical Techn. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Helius Medical Techn Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Helius Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Helius Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Helius Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Helius Medical Outstanding Bonds

Helius Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Helius Medical Techn uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Helius bonds can be classified according to their maturity, which is the date when Helius Medical Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Helius Medical Predictive Daily Indicators

Helius Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Helius Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Helius Medical Forecast Models

Helius Medical's time-series forecasting models are one of many Helius Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Helius Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Helius Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Helius Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Helius shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Helius Medical. By using and applying Helius Stock analysis, traders can create a robust methodology for identifying Helius entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(12.37)(12.99)
Operating Profit Margin(17.37)(18.24)
Net Loss(12.37)(12.99)
Gross Profit Margin 0.11  0.10 

Current Helius Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Helius analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Helius analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.0Hold1Odds
Helius Medical Technologies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Helius analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Helius stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Helius Medical Techn, talking to its executives and customers, or listening to Helius conference calls.
Helius Analyst Advice Details

Helius Stock Analysis Indicators

Helius Medical Technologies stock analysis indicators help investors evaluate how Helius Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Helius Medical shares will generate the highest return on investment. By understating and applying Helius Medical stock analysis, traders can identify Helius Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow14.5 M
Common Stock Shares Outstanding607.9 K
Total Stockholder Equity2.4 M
Property Plant And Equipment Net230 K
Cash And Short Term Investments5.2 M
Cash5.2 M
Accounts Payable531 K
Net Debt-5.1 M
50 Day M A0.6658
Total Current Liabilities1.9 M
Other Operating Expenses13.1 M
Non Current Assets Total254 K
Non Currrent Assets Other140 K
Stock Based Compensation1.6 M

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.